Lastly, the well-established oncogenes KRAS and MYC were also identified within melanoma-derived EV, supporting a potential role for EV-mediated transfer of these tumorigenic factors in promoting malignant transformation and tumor progression. The gene discussed is KRAS; the disease is melanoma.